Engage ~ Alterations in health/Alterations in Endocrine function: Hypoglycemia

Pathophysiology of Hypoglycemia

Definition: Hypoglycemia refers to a failure in the body's glucose homeostasis mechanisms, primarily regulated by the pancreas and liver.
- Glucose levels in the blood fluctuate to maintain low blood glucose concentrations through processes such as gluconeogenesis and glycogenolysis.
- Hypoglycemia occurs when blood glucose levels fall below a certain threshold:
- Fasting blood glucose: $70 ext{ mg/dL}$ or less
- Random blood glucose: $74 ext{ mg/dL}$ or less
- Insufficient glucose availability to meet the metabolic demands of the body's cells leads to hypoglycemia.

Physiological Response

Triggering Mechanisms: Hypoglycemia stimulates the sympathetic nervous system leading to several physiological responses:
- Hormonal Release: Norepinephrine released from adrenal glands raises blood glucose levels by mobilizing glucose reserves.
- Pancreatic Response: The pancreas secretes glucagon, further regulating blood glucose levels.
- Brain Dependency: Glucose is the primary energy source for the brain; without it, neuroglycopenia can ensue.

Neuroglycopenia

Definition: Neuroglycopenia manifests as brain dysfunction due to insufficient glucose, leading to symptoms like:
- Dizziness
- Confusion
- Blurred vision
- Coma

Etiology and Risk Factors

Demographics: Most common in individuals with:
- Type 1 Diabetes Mellitus (T1DM), often due to medication management difficulties such as incorrect dosing or timing.
Causes of Hypoglycemia in T1DM Include:
- Excess insulin administration or hypoglycemic medications
- Early administration of insulin
- Malfunctioning insulin pumps
- Inadequate food intake
- Increased physical activity without caloric compensation
- Skipping meals

Epidemiology

Prevalence: Individuals with T1DM have a heightened risk of hypoglycemia, with about 4% of cases presenting in medical settings. In T2DM, the prevalence is between 1% to 3%.
- Many individuals do not seek treatment until symptoms become severe, indicating higher prevalence than reported.
Frequency: Average T1DM patients may experience one hypoglycemic event weekly, and many more mild, unnoticed episodes, particularly nocturnal hypoglycemia.

Risk Factors for Hypoglycemia

Client Characteristics:
- Predisposing conditions like diabetes or lack of awareness of early warning signs (e.g., shakiness).
Medication Effects:
- Higher risks associated with insulin dependency and use of sulfonylureas (medications like Glyburide, Glipizide).
Other medications leading to hypoglycemia include:
- Antiarrhythmics (e.g., Quinidine)
- Antibiotics (e.g., Levofloxacin)
- Beta blockers (e.g., Atenolol)
- NSAIDs (e.g., Indomethacin)
- Metformin when used with sulfonylureas
- SGLT2 inhibitors (e.g., Canagliflozin)
- Thiazolidinediones (e.g., Pioglitazone)

Comorbidities and Complications

Individuals with DM who experience hypoglycemia face:
- Increased mortality risk
- Higher likelihood of cardiovascular events (e.g., stroke, heart failure)
Comorbidities include:
- Hypertension
- Renal disease
- Psychological issues
- Cancer history
- History of strokes or cardiac disease

Impact on Overall Health

Frequent hypoglycemic incidents can result in:
- Reduced overall health quality
- Increased anxiety and fear regarding future episodes
- Greater work absenteeism and diminished effectiveness in daily activities
Social Implications: Increased stress in personal relationships and difficulties operating motor vehicles.
Physiological Changes: Repeated episodes may lead to hypoglycemia unawareness, where patients do not present early symptoms until critical hypoglycemia occurs.
Sleep Disturbances: Nocturnal hypoglycemia may lead to:
- Nightmares
- Night sweats
- Irritability
- Confusion
- Crying out during sleep

Effects of Hypoglycemia on Body Systems

Circulatory: Rapid heartbeat and palpitations.
Endocrine: Delayed hormonal response, leading to missed warning signs.
Gastrointestinal: Symptoms of hunger and nausea.
Neurological: Weakness, lack of coordination, chills, dizziness, confusion, headaches, and blurred vision.

Clinical Presentation

Common Manifestations:
- Shakiness, anxiety, chills, diaphoresis, hunger
- Emotional changes include irritability and mood swings.
- Physical manifestations: fatigue, low energy, clumsiness, confusion, dizziness, vision problems, pallor, tachycardia, tingling and numbness in the mouth and limbs.
Severe Reactions: May progress to seizures or coma.

Classification of Hypoglycemia (American Diabetes Association)

Level 1: Blood glucose between $54 ext{ mg/dL}$ and $70 ext{ mg/dL}$ .
Level 2: Blood glucose less than $54 ext{ mg/dL}$ .
Level 3: Not dependent on blood glucose level; patients present with impaired mental/physical status that necessitates treatment.

Laboratory and Diagnostic Testing

Blood Glucose Testing: Confirmatory tests for hypoglycemia establish diagnosis:
- Fasting blood glucose: $70 ext{ mg/dL}$ or less
- Random blood glucose: less than $74 ext{ mg/dL}$ .
Critical Low Values:
- For adult males: less than $50 ext{ mg/dL}$
- For adult females: less than $40 ext{ mg/dL}$ .
Individualized Targets: Especially critical for clients with hypoglycemia unawareness; thresholds for treatment may need adjustment.
Continuous Glucose Monitors (CGMs):
- Function: Monitor glucose levels via skin sensors, offering real-time data or intermittent checks based on device type.
- Advantages: Reduce hypoglycemic events and are particularly helpful for patients with hypoglycemia unawareness.
Limitations: Accuracy can decline with poor oxygenation or extreme temperatures.

Role of the Nurse

Monitoring and Education: Continuous assessment of blood glucose, medications administration, and patient education.
Testing Methods: Blood glucose is assessed via capillary or venous sampling, employing point-of-care devices.
- Inconclusive point-of-care results necessitate central lab analysis.
Immediate Care: If the patient is alert, provide 15-30 grams of fast-acting carbohydrates according to the 15-15 rule.
When Alertness is Compromised: Administer glucagon if the patient is unable to swallow; IV dextrose may be warranted in a healthcare setting.

Treatment of Hypoglycemia

15-15 Rule:
- Verify consciousness and ability to ingest glucose.
- Administer at least 15 grams of fast-acting carbs, wait 15 minutes, and recheck glucose.
- If still hypoglycemic, repeat with another 15 grams.
Examples of Fast-Acting Carbohydrates:
- 3-4 glucose tablets
- 6-8 candies or gummies
- 8 oz low-fat or skim milk
- 1 tbsp corn syrup, sugar, or honey
- 4-5 crackers
- 1 tube of glucose gel

Environmental and Cultural Considerations

Risk Variability: Changing work schedules, time zone travel, and increased physical activity can escalate hypoglycemic risk.
Food Insecurity: Variable access to nutritious food increases hypoglycemic episodes.
Cultural Practices: Specific fasting traditions can impact glycemic control; adjusting medications and monitoring is essential based on individual needs.

Client Education

Focus Areas:
- Understanding hypoglycemia manifestations
- Importance & frequency of blood glucose monitoring
- Dietary considerations, including necessary rapid glucose sources
Emergency Planning: Clients and close contacts should be instructed on glucagon administration and emergency protocol (contacting 911).

Nursing Process for Hypoglycemia

Assessment: Identify symptoms, level of consciousness, and blood glucose levels.
Analysis: Focus on potential for unrecognized hypoglycemia and plan interventions accordingly.
Planning & Implementation: Strategies include monitoring glucose, ensuring dietary intake, administering medications, and collaborating with the healthcare team.
Evaluation: Assess blood glucose stabilization and manifestation resolution while evaluating client education effectiveness regarding hypoglycemia management.